{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:47:16Z","timestamp":1782578836522,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,12,11]],"date-time":"2007-12-11T00:00:00Z","timestamp":1197331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s12032-007-9031-1","type":"journal-article","created":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T15:14:14Z","timestamp":1197299654000},"page":"279-283","source":"Crossref","is-referenced-by-count":28,"title":["Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Ayla","family":"Acar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Onan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytug","family":"Uner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umit","family":"Bagriacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Atalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diclehan Kilic","family":"Unsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haldun","family":"Guner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,11]]},"reference":[{"key":"9031_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/gyno.1999.5533","volume":"5","author":"A Westerlund","year":"1999","unstructured":"Westerlund A, Apaja-Sarkkinen M, H\u00f6yhtya M, Puistola U, Turpeenniemi-Hujanen T. Gelatinase A-immunoreactive protein in ovarian lesions-prosnoctic value in epithelial ovarian cancer. Gynecol Oncol 1999;5:91\u20138.","journal-title":"Gynecol Oncol"},{"key":"9031_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/gyno.2001.6243","volume":"82","author":"E Lengyel","year":"2001","unstructured":"Lengyel E, Schmalfeldt B, Konik E, Sp\u00e4the K, H\u00e4rting K, Fenn A, Berger U, Fridman R, Schmitt M, Preehtel D, Kuhn W. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol 2001;82:291\u20138.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9031_CR3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/gyno.2001.6477","volume":"84","author":"X Wu","year":"2002","unstructured":"Wu X, Li H, Kang L, Li L, Wang W, Shan B. Activated matrix metalloproteinase-2- a potential marker of prognosis for epithelial ovarian cancer. Gynecol Oncol 2002;84 (1):126\u201334.","journal-title":"Gynecol Oncol"},{"key":"9031_CR4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","volume":"13","author":"J Westermarck","year":"1999","unstructured":"Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781\u201392.","journal-title":"FASEB J"},{"key":"9031_CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463\u2013516.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"9031_CR6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ijc.11288","volume":"106","author":"SM Ranuncolo","year":"2003","unstructured":"Ranuncolo SM, Armanasco E, Cresta C, Bal De Kier Joffe E, Puricelli L. Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients. Int J Cancer 2003;106:745\u201351.","journal-title":"Int J Cancer"},{"key":"9031_CR7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/carcin\/22.7.1035","volume":"22","author":"S Kermorgant","year":"2001","unstructured":"Kermorgant S, Aparicio T, Dessirier V, Lewin MJ, Lehy T. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis 2001;22:1035\u201342.","journal-title":"Carcinogenesis"},{"key":"9031_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1023039230052","volume":"22","author":"T Shiomi","year":"2003","unstructured":"Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003;22:145\u201352.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"9031_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.20697","volume":"114","author":"FQ Wang","year":"2005","unstructured":"Wang FQ, So J, Reierstad S, Fishman DA. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 2005;114(1):19\u201331.","journal-title":"Int J Cancer"},{"key":"9031_CR10","doi-asserted-by":"crossref","unstructured":"Maurel J, Nadal C, Garcia-Albeniz X, Gallego R, Carcereny E, Almendro V, Marmol M, Gallardo E, Maria Auge J, Longaron R, Martinez-Fernandez A, Molina R, Castells A, Gascon P. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 2007 May 8; [Epub ahead of print].","DOI":"10.1002\/ijc.22799"},{"key":"9031_CR11","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2379::AID-CNCR17>3.0.CO;2-Y","volume":"78","author":"K Gohji","year":"1996","unstructured":"Gohji K, Fujimoto N, Komiyama T, Fujii A, Ohkawa J, Kamidono S, Nakajima M. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer 1996;78:2379\u201387.","journal-title":"Cancer"},{"key":"9031_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3835(01)00657-7","volume":"173","author":"SM Sheen-Chen","year":"2001","unstructured":"Sheen-Chen SM, Chen HS, Eng HL, Sheen CC, Chen WJ. Serum levels of matrix metalloproteinase 2 in patients with breast cancer. Cancer Lett 2001;173:79\u201382 .","journal-title":"Cancer Lett"},{"key":"9031_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2006.02.026","volume":"371","author":"SC Liu","year":"2006","unstructured":"Liu SC, Yang SF, Yeh KT, Yeh CM, Chiou HL, Lee CY, Chou MC, Hsieh YS. Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clin Chim Acta 2006;371:92\u20136.","journal-title":"Clin Chim Acta"},{"key":"9031_CR14","first-page":"1085","volume":"20","author":"A Oberg","year":"2000","unstructured":"Oberg A, Hoyhtya M, Tavelin B, Stenling R, Lindmark G. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res 2000;20:1085\u201391.","journal-title":"Anticancer Res"},{"key":"9031_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1023\/A:1006580415796","volume":"16","author":"MM Pacheco","year":"1998","unstructured":"Pacheco MM, Mourao M, Mantovani EB, Nishimoto IN, Brentani MM. Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations. Clin Exp Metastasis 1998;16:577\u201385.","journal-title":"Clin Exp Metastasis"},{"key":"9031_CR16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0046-8177(97)90085-X","volume":"28","author":"N Kawano","year":"1997","unstructured":"Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K, Kitamura H. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 1997;28:613\u201322.","journal-title":"Hum Pathol"},{"key":"9031_CR17","first-page":"348","volume":"54","author":"U Coskun","year":"2007","unstructured":"Coskun U, Yamac D, Gulbahar O, Sancak B, Karaman N, Ozkan S. Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response? Neoplasma 2007;54:348\u201352.","journal-title":"Neoplasma"},{"key":"9031_CR18","doi-asserted-by":"crossref","unstructured":"F.I.G.O. News. Int J Gynecol Obstet 1989;28:189\u201393.","DOI":"10.1016\/0020-7292(89)90482-7"},{"key":"9031_CR19","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-04-2478","volume":"11","author":"J Nikkola","year":"2005","unstructured":"Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 2005;11:5158\u201366.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9031_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0092-8674(91)90642-C","volume":"64","author":"LA Liotta","year":"1991","unstructured":"Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64(2):327\u201336.","journal-title":"Cell"},{"key":"9031_CR21","first-page":"190","volume":"56","author":"NB Liabakk","year":"1996","unstructured":"Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996;56:190\u20136.","journal-title":"Cancer Res"},{"key":"9031_CR22","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/1097-0142(19921215)70:12<2747::AID-CNCR2820701204>3.0.CO;2-5","volume":"70","author":"I Shima","year":"1992","unstructured":"Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992;70:2747\u201353.","journal-title":"Cancer"},{"key":"9031_CR23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/ijc.21989","volume":"119","author":"SB Somiari","year":"2006","unstructured":"Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, Shriver CD. Circulating MMP2 and MMP9 in breast cancer\u2014potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 2006;119:1403\u201311.","journal-title":"Int J Cancer"},{"key":"9031_CR24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s005950200081","volume":"32","author":"H Sasaki","year":"2002","unstructured":"Sasaki H, Yukiue H, Kobayashi Y, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y. Elevated serum pro-MMP2 levels in patients with stage IV thymoma. Surg Today 2002;32:482\u20136.","journal-title":"Surg Today"},{"key":"9031_CR25","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/ijc.22067","volume":"119","author":"SM Sillanpaa","year":"2006","unstructured":"Sillanpaa SM, Anttila MA, Voutilainen KA, Ropponen KM, Sironen RK, Saarikoski SV, Kosma VM. Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression. Int J Cancer 2006;119:1792\u20139.","journal-title":"Int J Cancer"},{"key":"9031_CR26","first-page":"2799","volume":"15","author":"GG Garzetti","year":"1995","unstructured":"Garzetti GG, Ciavattini A, Lucarini G, Goteri G, de e Nictolis M, Garbisa S, Masiero L, Romanini C, Graziella B. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications. Anticancer Res. 1995;15:2799\u2013804.","journal-title":"Anticancer Res"},{"key":"9031_CR27","unstructured":"Demeter A, Sziller I, Csapo Z, Olah J, Keszler G, Jeney A, Papp Z, Staub M. Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer Anticancer Res 2005;25:2885\u20139."},{"key":"9031_CR28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/105072502760258622","volume":"12","author":"J Komorowski","year":"2002","unstructured":"Komorowski J, Pasieka Z, Jankiewicz-Wika J, Stepien H. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer. Thyroid 2002;12:655\u201362.","journal-title":"Thyroid"},{"key":"9031_CR29","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1172\/JCI117619","volume":";94","author":"ZS Galis","year":"1994","unstructured":"Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994 ;94:2493\u2013503.","journal-title":"J Clin Invest"},{"key":"9031_CR30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2174\/0929867053507270","volume":"12","author":"MH Tayebjee","year":"2005","unstructured":"Tayebjee MH, Lip GY, MacFadyen RJ. Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. Curr Med Chem 2005;12:917\u201325.","journal-title":"Curr Med Chem"},{"key":"9031_CR31","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/jc.2005-0648","volume":"91","author":"KC Lewandowski","year":"2006","unstructured":"Lewandowski KC, Komorowski J, O\u2019Callaghan CJ, Tan BK, Chen J, Prelevic GM, Randeva HS. Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1173\u20137.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-9031-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-007-9031-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-9031-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:33Z","timestamp":1559442153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-007-9031-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,11]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9031"],"URL":"https:\/\/doi.org\/10.1007\/s12032-007-9031-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,11]]}}}